Introduction to the GI-MAP® (DNA qPCR Stool Analysis).
Wed, Mar 25, 2020 6:00 PM – 7:00 PM
Learn to Optimize Patient Outcomes Using the GI-MAP®:
Since the inception of the Human Microbiome Project, the functional medicine community has learned how critically important gut health is in the diagnosis and treatment of disease. In fact, new discoveries are being made daily that link the gut microbiome to autoimmune disease, chronic fatigue, diabetes, and myriad other conditions.
The GI-MAP (Microbial Assay Plus) is an advanced diagnostic DNA stool test that practitioners use to uncover the root cause of patient complaints. The test identifies bacterial infections, yeast, parasites, and viruses that, once identified and treated, help patients overcome symptoms that often reside outside of the gut.
Attend our webinar and learn why practitioners worldwide choose the GI-MAP stool test to treat patients with complex conditions.
- What Quantitative Polymerase Chain Reaction (qPCR) DNA technology is, and why it provides the reliable and quantitative results practitioners need. qPCR enhances clinical utility by quantitatively evaluating keystone bacterial species, as well as opportunistic bacteria that may negatively impact patient health.
- How to use the GI-MAP test report to evaluate dysbiosis patterns and use the information to create targeted treatment plans that improve microbial balance and optimize patient outcomes.
- How Gastrointestinal Metabolic Markers broaden the overall picture of patient health. We’ll discuss significant markers that impact health, including SIgA, Calprotectin, Elastase-1, and more.
Let’s Put it All Together:
This webinar will give you the tools you need to incorporate the GI-MAP test into your practice, and help your patients begin their journey to wellness.